ArticleJournal of molecular and cellular cardiology2023

RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.

Jeffrey Schmeckpeper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.